Literature DB >> 29307284

Environmental basis of primary biliary cholangitis.

Atsushi Tanaka1, Patrick Sc Leung2, M Eric Gershwin2.   

Abstract

Autoimmunity is a consequence of both genetic and environmental factors, occurring in genetically susceptible hosts with environmental triggers. While genome-wide association studies have revealed a number of susceptible genes contributing to etiology, the environmental triggers remain poorly understood. Primary biliary cholangitis, formally known as primary biliary cirrhosis, is considered a model autoimmune disease for which our group has extensively evaluated environmental factors involved in its etiology. Bacterial infection and xenobiotics have been proposed as candidate environmental factors that may explain tolerance breakdown and production of primary biliary cholangitis-specific antimitochondrial autoantibodies. Large-scale case-control studies have consistently detected an association of primary biliary cholangitis with urinary tract infections caused by Escherichia coli, as E. coli PDC-E2 is molecularly similar to human PDC-E2, the immunodominant target of AMAs. Another bacterium of interest is Novosphingobium aromaticivorans, a ubiquitous xenobiotic-metabolizing bacterium that produces lipoylated proteins, which are highly reactive with sera from primary biliary cholangitis patients. Regarding xenobiotics, case-control studies have suggested that frequent use of nail polish is associated with an increased susceptibility to primary biliary cholangitis. We found that 2-octynamide, the conjugate derived from 2-octynoic acid present in cosmetics, lipsticks, and some chewing gums, was unique in both its quantitative structure-activity relationship analysis and reactivity with primary biliary cholangitis sera. 2-nonyamide is another xenobiotic that also has the optimal chemical structure for xenobiotic modification of the PDC-E2 epitope, as demonstrated by the enhanced epitope recognition with AMA-positive PBC sera. Moreover, we found that C57BL/6 mice immunized with 2-octynoic acid-BSA possess many of the features characteristic to primary biliary cholangitis. Impact statement Autoimmunity is believed to develop in genetically susceptible hosts with triggers from the environment. Researchers have recently demonstrated that bacteria and xenobiotics commonly present in our environment are potential triggers of tolerance breakdown against autoantigens and autoimmunity, particularly in primary biliary cholangitis (PBC). The link between xenobiotics and PBC has been further confirmed with the establishment of PBC model mice by immunizing mice with xenobiotics.

Entities:  

Keywords:  Environment; animal models; anti-mitochondrial autoantibodies; autoimmune; genetic background; primary biliary cholangitis

Mesh:

Substances:

Year:  2018        PMID: 29307284      PMCID: PMC5788149          DOI: 10.1177/1535370217748893

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  62 in total

1.  Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.

Authors:  Ruqi Tang; Yiran Wei; Yanmei Li; Weihua Chen; Haoyan Chen; Qixia Wang; Fan Yang; Qi Miao; Xiao Xiao; Haiyan Zhang; Min Lian; Xiang Jiang; Jun Zhang; Qin Cao; Zhuping Fan; Maoying Wu; Dekai Qiu; Jing-Yuan Fang; Aftab Ansari; M Eric Gershwin; Xiong Ma
Journal:  Gut       Date:  2017-02-17       Impact factor: 23.059

Review 2.  Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.

Authors:  Beidi Chen; Luxi Sun; Xuan Zhang
Journal:  J Autoimmun       Date:  2017-03-23       Impact factor: 7.094

Review 3.  Immunity, tolerance and autoimmunity in the liver: A comprehensive review.

Authors:  Derek G Doherty
Journal:  J Autoimmun       Date:  2015-09-07       Impact factor: 7.094

4.  Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.

Authors:  Brian K Chung; Bardia T Guevel; Gary M Reynolds; D B R K Gupta Udatha; Eva Kristine Klemsdal Henriksen; Zania Stamataki; Gideon M Hirschfield; Tom Hemming Karlsen; Evaggelia Liaskou
Journal:  J Autoimmun       Date:  2016-10-24       Impact factor: 7.094

5.  Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Authors:  Sabine Oertelt; Zhe-Xiong Lian; Chun-Mei Cheng; Ya-Hui Chuang; Kerstien A Padgett; Xiao-Song He; William M Ridgway; Aftab A Ansari; Ross L Coppel; Ming O Li; Richard A Flavell; Mitchell Kronenberg; Ian R Mackay; M Eric Gershwin
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 6.  Definition of human autoimmunity--autoantibodies versus autoimmune disease.

Authors:  Ana Lleo; Pietro Invernizzi; Bin Gao; Mauro Podda; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-04       Impact factor: 9.754

Review 7.  Animal models of primary biliary cirrhosis.

Authors:  Jinjun Wang; Guo-Xiang Yang; Koichi Tsuneyama; M Eric Gershwin; William M Ridgway; Patrick S C Leung
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

Review 8.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

9.  The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase.

Authors:  J Van de Water; M E Gershwin; P Leung; A Ansari; R L Coppel
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

10.  Geographic clusters of primary biliary cirrhosis.

Authors:  Saif Abu-Mouch; Carlo Selmi; Gordon D Benson; Thomas P Kenny; Pietro Invernizzi; Massimo Zuin; Mauro Podda; Lorenzo Rossaro; M Eric Gershwin
Journal:  Clin Dev Immunol       Date:  2003 Jun-Dec
View more
  8 in total

Review 1.  Pathogen infections and primary biliary cholangitis.

Authors:  A Tanaka; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2018-09-17       Impact factor: 4.330

Review 2.  The Role of Epigenetics in Primary Biliary Cholangitis.

Authors:  Alessio Gerussi; Elvezia Maria Paraboschi; Claudio Cappadona; Chiara Caime; Eleonora Binatti; Laura Cristoferi; Rosanna Asselta; Pietro Invernizzi
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

3.  Kupffer Cells Regulate Natural Killer Cells Via the NK group 2, Member D (NKG2D)/Retinoic Acid Early Inducible-1 (RAE-1) Interaction and Cytokines in a Primary Biliary Cholangitis Mouse Model.

Authors:  Hai-Yan Fu; Wei-Min Bao; Cai-Xia Yang; Wei-Ju Lai; Jia-Min Xu; Hai-Yan Yu; Yi-Na Yang; Xu Tan; Ajay Kumar Gupta; Ying-Mei Tang
Journal:  Med Sci Monit       Date:  2020-06-29

Review 4.  Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.

Authors:  Aleksandar Arsenijevic; Bojana Stojanovic; Jelena Milovanovic; Dragana Arsenijevic; Nebojsa Arsenijevic; Marija Milovanovic
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

Review 5.  Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 11.413

6.  Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.

Authors:  Teresa Gastañaga-Holguera; Marta Calvo; Laura Gómez-Irwin; Isabel Campo Gesto; Virginia González-González; Marta Vidaurreta
Journal:  JBRA Assist Reprod       Date:  2021-10-04

Review 7.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

Review 8.  Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.

Authors:  Chang Wang; Ying Shi; Xiaomei Wang; Heming Ma; Quan Liu; Yanhang Gao; Junqi Niu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.